Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

10-Year Update on Study Results Submitted to ClinicalTrials.gov.

Zarin DA, Fain KM, Dobbins HD, Tse T, Williams RJ.

N Engl J Med. 2019 Nov 14;381(20):1966-1974. doi: 10.1056/NEJMsr1907644. No abstract available.

PMID:
31722160
2.

The Culture of Trial Results Reporting at Academic Medical Centers.

Zarin DA.

JAMA Intern Med. 2019 Oct 28. doi: 10.1001/jamainternmed.2019.4200. [Epub ahead of print] No abstract available.

PMID:
31657846
3.

Harms From Uninformative Clinical Trials.

Zarin DA, Goodman SN, Kimmelman J.

JAMA. 2019 Jul 25. doi: 10.1001/jama.2019.9892. [Epub ahead of print] No abstract available.

PMID:
31343666
4.

Lost Evidence From Registered Large Long-Unpublished Randomized Controlled Trials: A Survey.

Tatsioni A, Karassa FB, Goodman SN, Zarin DA, Fanelli D, Ioannidis JPA.

Ann Intern Med. 2019 May 7. doi: 10.7326/M19-0440. [Epub ahead of print] No abstract available.

PMID:
31060046
5.

Universal Funder Responsibilities That Advance Social Value.

Bierer BE, Strauss DH, White SA, Zarin DA.

Am J Bioeth. 2018 Nov;18(11):30-32. doi: 10.1080/15265161.2018.1523498. No abstract available.

PMID:
30475185
6.

Reaping the Bounty of Publicly Available Clinical Trial Consent Forms.

Lynch HF, Largent EA, Zarin DA.

IRB. 2017 Nov-Dec;39(6):10-15.

7.

How to avoid common problems when using ClinicalTrials.gov in research: 10 issues to consider.

Tse T, Fain KM, Zarin DA.

BMJ. 2018 May 25;361:k1452. doi: 10.1136/bmj.k1452. No abstract available.

8.

Lockbox for Registered Trials of Unapproved Devices.

Tse T, Bergeris A, Zarin DA.

N Engl J Med. 2018 Mar 15;378(11):1064. doi: 10.1056/NEJMc1800780. No abstract available.

9.

Results Reporting for Trials With the Same Sponsor, Drug, and Condition in ClinicalTrials.gov and Peer-Reviewed Publications.

Fain KM, Rajakannan T, Tse T, Williams RJ, Zarin DA.

JAMA Intern Med. 2018 Jul 1;178(7):990-992. doi: 10.1001/jamainternmed.2018.0263. No abstract available.

10.

Trialists' Intent to Share Individual Participant Data as Disclosed at ClinicalTrials.gov.

Bergeris A, Tse T, Zarin DA.

JAMA. 2018 Jan 23;319(4):406-408. doi: 10.1001/jama.2017.20581. No abstract available.

11.

Update on Trial Registration 11 Years after the ICMJE Policy Was Established.

Zarin DA, Tse T, Williams RJ, Rajakannan T.

N Engl J Med. 2017 Jan 26;376(4):383-391. doi: 10.1056/NEJMsr1601330. No abstract available.

12.

Trial Reporting in ClinicalTrials.gov - The Final Rule.

Zarin DA, Tse T, Williams RJ, Carr S.

N Engl J Med. 2016 Nov 17;375(20):1998-2004. Epub 2016 Sep 16. No abstract available.

13.

Previously unidentified duplicate registrations of clinical trials: an exploratory analysis of registry data worldwide.

van Valkenhoef G, Loane RF, Zarin DA.

Syst Rev. 2016 Jul 15;5(1):116. doi: 10.1186/s13643-016-0283-8.

14.

ClinicalTrials.gov and Drugs@FDA: A Comparison of Results Reporting for New Drug Approval Trials.

Schwartz LM, Woloshin S, Zheng E, Tse T, Zarin DA.

Ann Intern Med. 2016 Sep 20;165(6):421-30. doi: 10.7326/M15-2658. Epub 2016 Jun 14.

15.

Sharing Individual Participant Data (IPD) within the Context of the Trial Reporting System (TRS).

Zarin DA, Tse T.

PLoS Med. 2016 Jan 19;13(1):e1001946. doi: 10.1371/journal.pmed.1001946. eCollection 2016 Jan. Review. No abstract available.

16.

Terminated Trials in the ClinicalTrials.gov Results Database: Evaluation of Availability of Primary Outcome Data and Reasons for Termination.

Williams RJ, Tse T, DiPiazza K, Zarin DA.

PLoS One. 2015 May 26;10(5):e0127242. doi: 10.1371/journal.pone.0127242. eCollection 2015.

17.

Trial-results reporting and academic medical centers.

Zarin DA, Tse T, Ross JS.

N Engl J Med. 2015 Jun 11;372(24):2371-2. doi: 10.1056/NEJMc1505965. Epub 2015 May 20. No abstract available.

PMID:
25992618
18.

The proposed rule for U.S. clinical trial registration and results submission.

Zarin DA, Tse T, Sheehan J.

N Engl J Med. 2015 Jan 8;372(2):174-80. doi: 10.1056/NEJMsr1414226. Epub 2014 Dec 24. No abstract available.

19.

Independent data monitoring committees: preparing a path for the future.

Hess CN, Roe MT, Gibson CM, Temple RJ, Pencina MJ, Zarin DA, Anstrom KJ, Alexander JH, Sherman RE, Fiedorek FT, Mahaffey KW, Lee KL, Chow SC, Armstrong PW, Califf RM.

Am Heart J. 2014 Aug;168(2):135-41.e1. doi: 10.1016/j.ahj.2014.05.003. Epub 2014 May 15.

20.

Reporting discrepancies between the ClinicalTrials.gov results database and peer-reviewed publications.

Hartung DM, Zarin DA, Guise JM, McDonagh M, Paynter R, Helfand M.

Ann Intern Med. 2014 Apr 1;160(7):477-83. doi: 10.7326/M13-0480.

21.

Federal human research oversight of clinical trials in the United States.

Zarin DA, Tse T, Menikoff J.

JAMA. 2014 Mar 5;311(9):960-1. doi: 10.1001/jama.2013.284306. No abstract available.

22.

Participant-level data and the new frontier in trial transparency.

Zarin DA.

N Engl J Med. 2013 Aug 1;369(5):468-9. doi: 10.1056/NEJMe1307268. No abstract available.

23.

Clarification about ClinicalTrials.gov.

Zarin DA, Tse T.

IRB. 2013 May-Jun;35(3):19. No abstract available.

PMID:
23822048
24.

Trust but verify: trial registration and determining fidelity to the protocol.

Zarin DA, Tse T.

Ann Intern Med. 2013 Jul 2;159(1):65-7. doi: 10.7326/0003-4819-159-1-201307020-00011. No abstract available.

PMID:
23817705
25.

Unambiguous identification of obesity trials.

Zarin DA, Tse T.

N Engl J Med. 2013 Feb 7;368(6):580-1. doi: 10.1056/NEJMc1215018. No abstract available.

PMID:
23388022
26.

Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.

Califf RM, Zarin DA, Kramer JM, Sherman RE, Aberle LH, Tasneem A.

JAMA. 2012 May 2;307(17):1838-47. doi: 10.1001/jama.2012.3424.

PMID:
22550198
27.

Factual Errors about ClinicalTrials.gov and other federal mandates in special report by Shuster.

Zarin DA.

Clin Transl Sci. 2012 Apr;5(2):217; author reply 217. doi: 10.1111/j.1752-8062.2012.00410.x. No abstract available.

28.

Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis.

Ross JS, Tse T, Zarin DA, Xu H, Zhou L, Krumholz HM.

BMJ. 2012 Jan 3;344:d7292. doi: 10.1136/bmj.d7292.

29.

The ClinicalTrials.gov results database--update and key issues.

Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC.

N Engl J Med. 2011 Mar 3;364(9):852-60. doi: 10.1056/NEJMsa1012065.

30.

The effect of funding source on outcome reporting among drug trials.

Zarin DA, Tse T.

Ann Intern Med. 2011 Jan 18;154(2):137-8; author reply 138. doi: 10.7326/0003-4819-154-2-201101180-00020. No abstract available.

PMID:
21242372
31.

Registration of observational studies: is it time?

Williams RJ, Tse T, Harlan WR, Zarin DA.

CMAJ. 2010 Oct 19;182(15):1638-42. doi: 10.1503/cmaj.092252. Epub 2010 Jul 19. No abstract available.

32.

Considering usual medical care in clinical trial design.

Dawson L, Zarin DA, Emanuel EJ, Friedman LM, Chaudhari B, Goodman SN.

PLoS Med. 2009 Sep;6(9):e1000111. doi: 10.1371/journal.pmed.1000111. Epub 2009 Sep 29. No abstract available.

33.

Update on Registration of Clinical Trials in ClinicalTrials.gov.

Tse T, Williams RJ, Zarin DA.

Chest. 2009 Jul;136(1):304-305. doi: 10.1378/chest.09-1219. Review. No abstract available.

34.

Reporting "basic results" in ClinicalTrials.gov.

Tse T, Williams RJ, Zarin DA.

Chest. 2009 Jul;136(1):295-303. doi: 10.1378/chest.08-3022. Review. No abstract available.

35.

Clinical trials registry expands. Interview by Bridget M. Kuehn.

Zarin DA.

JAMA. 2009 Jul 1;302(1):22. doi: 10.1001/jama.2009.891. No abstract available.

PMID:
19567428
36.

Tracking health services research studies.

Zarin DA, Tse T.

JAMA. 2008 Nov 19;300(19):2252; author reply 2252. doi: 10.1001/jama.2008.612. No abstract available.

PMID:
19017910
37.

Medicine. Moving toward transparency of clinical trials.

Zarin DA, Tse T.

Science. 2008 Mar 7;319(5868):1340-2. doi: 10.1126/science.1153632. No abstract available.

38.

Issues in the registration of clinical trials.

Zarin DA, Ide NC, Tse T, Harlan WR, West JC, Lindberg DA.

JAMA. 2007 May 16;297(19):2112-20.

PMID:
17507347
39.

Registering a clinical trial in ClinicalTrials.gov.

Zarin DA, Keselman A.

Chest. 2007 Mar;131(3):909-912. doi: 10.1378/chest.06-2450. Epub 2007 Feb 15. No abstract available.

PMID:
17303677
40.

Salvation by registration.

Drazen JM, Zarin DA.

N Engl J Med. 2007 Jan 11;356(2):184-5. No abstract available.

41.

Clarifying a misunderstanding on clinical trial registry.

Zarin DA.

CMAJ. 2006 Jan 17;174(2):203-6; author reply 206. No abstract available.

42.

Trial Registration at ClinicalTrials.gov between May and October 2005.

Zarin DA, Tse T, Ide NC.

N Engl J Med. 2005 Dec 29;353(26):2779-87.

43.

Challenges in systematic reviews of diagnostic technologies.

Tatsioni A, Zarin DA, Aronson N, Samson DJ, Flamm CR, Schmid C, Lau J.

Ann Intern Med. 2005 Jun 21;142(12 Pt 2):1048-55. Review.

PMID:
15968029
44.

Clinical trial registration.

Zarin DA.

N Engl J Med. 2005 Apr 14;352(15):1611. No abstract available.

PMID:
15829551
45.

Concomitant pharmacotherapy among youths treated in routine psychiatric practice.

Duffy FF, Narrow WE, Rae DS, West JC, Zarin DA, Rubio-Stipec M, Pincus HA, Regier DA.

J Child Adolesc Psychopharmacol. 2005 Feb;15(1):12-25.

PMID:
15741782
47.

When should functional neuroimaging techniques be used in the diagnosis and management of Alzheimer's dementia? A decision analysis.

Kulasingam SL, Samsa GP, Zarin DA, Rutschmann OT, Patwardhan MB, McCrory DC, Schmechel DE, Matchar DB.

Value Health. 2003 Sep-Oct;6(5):542-50.

48.

A systematic review of pneumatic compression for treatment of chronic venous insufficiency and venous ulcers.

Berliner E, Ozbilgin B, Zarin DA.

J Vasc Surg. 2003 Mar;37(3):539-44. Review.

49.

Hyperbaric oxygen for treating wounds: a systematic review of the literature.

Wang C, Schwaitzberg S, Berliner E, Zarin DA, Lau J.

Arch Surg. 2003 Mar;138(3):272-9; discussion 280. Review.

PMID:
12611573
50.

Characteristics of psychiatric patients for whom financial considerations affect optimal treatment provision.

West JC, Pingitore D, Zarin DA.

Psychiatr Serv. 2002 Dec;53(12):1626-9.

PMID:
12461227

Supplemental Content

Loading ...
Support Center